Fill Finish Manufacturing Market worth $12.1 billion by 2025

 Overviews:

The study involved two major activities in estimating the current market size of the fill finish manufacturing market. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Market Size Estimation:

The revenue-based approach individually for instrument and consumable segments was used to estimate the global market size of the fill finish manufacturing market.

Expected Growth in Revenue Generation:

The global fill finish manufacturing market size is projected to reach USD 12.1 billion by 2025 from USD 7.5 billion in 2020, at a CAGR of 10.0% during the forecast period. The major factors driving the growth of this market include rising technological advancements in fill-finish manufacturing processes, the growth of the biopharmaceutical industry, and the rising adoption of prefilled syringes for parenteral dosage forms.

The consumables segment accounted for the largest share of the fill finish manufacturing market, by product, in 2019

Based on products, the fill-finish manufacturing industry is segmented broadly into consumables and instruments. The consumables segment accounted for the largest market share in 2019. The large share and high growth of this segment can primarily be attributed to the rising demand for prefilled syringes, wide applications of vials in lyophilization, and the growing use of disposable packaging for biologics.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=6249609

The integrated systems segment accounted for the largest share of instruments, by systems, in the fill finish manufacturing market in 2019

Based on systems, the instrument segment is divided into integrated systems and standalone systems.  The integrated systems segment dominated the market in 2019. Owing to its benefits over standalone systems, such as increase productivity and high-speed lines performing multiple operations on the same unit, are driving the adoption of integrated systems in fill-finish operations of drugs.

Europe accounted for the largest share of the fill finish manufacturing market in 2019

The large share of Europe in this market is attributed to factors such as growing focus on the development of biosimilar due to the patent expiry of key biologics products. In addition, well-established reimbursement systems for drugs have further enhanced the demand for biologics among patients by making them affordable to consume, and to fulfill this, biopharmaceutical companies have increased their production volumes and expand production capacities.

Key Players:

The major companies in the fill finish manufacturing market are Becton, Dickson and Company (US), Syntegon Technology GmbH (Germany), I.M.A. (Industria Macchine Automatiche) S.p.A. (Italy), Stevanato Group (Italy), West Pharmaceutical Services, Inc. (US), OPTIMA Packaging Group GmbH (Germany), Bausch+Strobel (Germany), Groninger & Co. GmbH (Germany), and Gerresheimer AG (Germany).

Download PDF Brochure for More Details@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=6249609

Global Apheresis Market is Expecting Major Revenue Surge by 2025

 Major Growth Influencing Factors:

The rising prevalence of chronic diseases and the growing number of trauma & injury cases, the rising demand for blood components and growing concerns regarding blood safety, and the favorable reimbursement for apheresis procedures are the major factors driving the growth of apheresis market.

Projected Revenue Surge During the Forecast Period:

The global apheresis market is projected to reach USD 2.7 billion by 2025 from USD 1.7 billion in 2019, at a CAGR of 8.1% during the forecast period.

The photopheresis segment is expected to grow at the highest CAGR during the forecast period

Based on application, the apheresis market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, photopheresis, and other applications. The photopheresis is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing prevalence of blood disorders and the rising demand for photopheresis in organ transplant rejection treatment.

The disposables segment is expected to grow at the highest CAGR during the forecast period

Based on products, the apheresis market is segmented into devices and disposables. The disposable segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to its recurrent use, increasing blood donations using apheresis devices, an increasing number of therapeutic apheresis procedures, and favorable reimbursement policies for apheresis procedures.

The centrifugation technology segment is expected to grow at the highest CAGR during the forecast period

Based on technology, the apheresis market is segmented into centrifugation technology and membrane separation technology. The centrifugation segment is expected to grow at the highest CAGR during the forecast period. This high growth can be attributed to the advantages offered by centrifugation over membrane separation, such as its high efficiency and its ability to separate all types of blood components

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=950

The hospitals and transfusion centers segment is expected to grow at the highest CAGR during the forecast period

On the basis of end user, the apheresis market has been segmented into blood collection centers and blood component providers, hospitals and transfusion centers, and other end users. The hospitals and transfusion centers segment is estimated to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing adoption of therapeutic apheresis in the treatment of various diseases, growing indications of therapeutic apheresis, and rising awareness of apheresis as a therapy.

North America accounted for the largest market share in 2018

North America accounted for the largest share of the apheresis market in 2018, followed by Europe. The large share of this region can be attributed to easier accessibility to advanced blood collection technologies, the presence of established healthcare infrastructure, and the increasing presence of leading apheresis companies in the country.

The therapeutic apheresis segment is expected to grow at the highest CAGR during the forecast period

Based on procedure, the apheresis market is segmented into automated blood collection (donor apheresis) and therapeutic apheresis. The therapeutic apheresis segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be attributed to the increasing adoption of apheresis procedures for the treatment of various neurological, blood, and renal diseases; the increasing prevalence of blood disorders; and favorable reimbursement policies for apheresis procedures.

Key Players:

The prominent players in this market are Terumo BCT, Inc. (US), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), Nikkiso Co., Ltd. (Japan), Macopharma SA (France), Miltenyi Biotec (Germany), Otsuka Holdings Co. Ltd. (Japan), Medica S.p.A. (Italy), Mallinckrodt plc (Ireland), Medicap Clinic GmbH (Germany), Lmb Technologies GmbH (Germany), Bioelettronica (Italy), Infomed (Switzerland), Cytosorbents Corporation (US), and Toray Medical Co. Ltd. (Japan), among other key players.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=950

This is How the Key Players are Dominating Global European Hemostats Market

 Hemostats help in controlling bleeding at the site of wound or performing various open surgeries. The different types of products used include thrombin-based hemostats, combination hemostats, oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, and collagen-based hemostats. Of these, combination hemostats are anticipated to grow at the highest rate in Europe, as they reduce the risk of side-effects post-application.

Overview of This Study:

The study involved four major activities to estimate the current size of the European hemostats market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Global Key Players:

Key players operating in the European hemostats market include B. Braun (Germany), Medtronic (Ireland), C. R. Bard (US), Takeda (Japan), and Baxter (US).

Growth Strategies:

The market for hemostats and sealants is anticipated to grow mainly due to the launch of the new products, M&A’s, and favorable reimbursement scenario in Europe. However, the increasing preference for minimally invasive surgeries and the reducing preference for the usage of hemostats while performing surgeries are expected to hinder the growth of this market during the forecast year.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=115823197

Projected Revenue Surge:

The European hemostats market is projected to reach USD 89 million by 2024 from USD 63 million in 2019, at a CAGR of 7.0%.

Major Growth Driving Factors:

Growth in this market is mainly driven by the favorable reimbursement scenario for the usage of hemostats in various surgeries. However, the shift towards minimally invasive surgeries over open surgeries is a major restraint for this market.

UK to grow at the highest rate during the forecast period (2019–2024)

The European hemostats market is geographically segmented into Germany, UK, France, Italy, and Spain. While Germany dominated the market in 2019, the UK is expected to register the highest CAGR in the market during the forecast period. Germany holds the largest share amongst all the European countries, owing to its larger patient population and comparatively higher number of surgeries, which will require the usage of hemostats and sealants.

Key questions addressed in the report:

# What are the growth opportunities in the Hemostats market across major countries in Europe in the future?
# What are the key drivers and restraints in the European Hemostats market?
# What are the key brands in the European Hemostats market?
# Which are the key countries in the European Hemostats market?
# What are the most preferred brands amongst end users?

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=115823197

Apheresis Market - Emerging Innovations & Global Future Forecasts

 Global Industry Growth Driving Factors:

The global apheresis market is primarily driven by the rising prevalence of chronic diseases and the growing number of trauma and injury cases, the increasing demand for source plasma from biopharmaceutical companies, the rising demand for blood components and growing concerns regarding blood safety, the increase in the number of complex surgical procedures, and the favorable reimbursement for apheresis procedures.

However, the high cost of apheresis devices & therapeutic apheresis procedures and installation of apheresis devices through the rental model, fewer blood donations using apheresis due to lack of awareness, and the stringent donor recruitment criteria are factors expected to limit market growth to a certain extent in the coming years.

Research Methodologies Followed for This Study:

Primary Research:

In the primary research process, industry experts from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Industry experts from the supply side include CEOs, vice presidents, marketing and sales directors, product managers, business development managers, technology and innovation directors of companies providing apheresis, key opinion leaders, and suppliers and distributors. The industry experts from the demand side include hospitals, blood collection centers, transfusion clinics, and healthcare payers.

Secondary Research:

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the apheresis market.

It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=950

Recent Developments:

# In July 2019, Baxter International Inc. (US) launched the PrisMax system in the US.
# In June 2019, Toray Medical Co. Ltd. (Japan) launched the TORAMYXIN device in the European region.
# In October 2019, Terumo BCT (US) collaborated with the UniCAR-Therapy Bio-Medicine Technology Co. (China). This collaboration aimed at advancing CAR T-cell therapies by creating a new Shanghai Center of Excellence. This development also helped Terumo widen its applications of apheresis and leukapheresis procedures.
# In August 2017, Fresenius Medical Care (Germany) acquired NxStage Medical, Inc. (US). This acquisition enabled Fresenius Medical Care to further expand its presence in the renal care and critical care area.

In 2018, the blood collection centers and blood component providers segment accounted for the largest share of the market

Based on end users, the apheresis market is segmented into blood collection centers and blood component providers, hospitals and transfusion centers, and other end users. In 2018, the blood collection centers and blood component providers segment accounted for the largest share of 67.5% of the global apheresis market. The large share of this end-user segment is mainly attributed to the rising number of blood component donations, a growing number of blood centers, and increasing awareness of blood collection.

Critical Questions Answered:

# Where will these developments take the industry in the mid-to-long term?
# Who are the major end users in the apheresis market, and what are the benefits they avail by implementing apheresis technology?
# What are the recent trends in the apheresis market?
# What are the major market dynamics and their impact on overall market growth?
# What is the global scenario of the apheresis market?

North America accounted for the largest share of the apheresis market in 2018

The apheresis market is segmented into five major regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the apheresis market. The large share of this region can be attributed to easier access to advanced blood collection technologies, the presence of established healthcare infrastructure, and the increasing presence of leading apheresis companies in the country.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=950

Human Organoids Market - Major Revenue Gains are Expected by 2025

 Major Growth Boosting Factors:

Increasing prevalence of transplantation, technological advancements and increased funding and public-private investments are the key factors driving the growth of the human organoids market.

Expected Growth in Revenue Generation:

The global human organoids market size is estimated to be USD 850 million in 2020 and projected to reach USD 1,901 million by 2025, at a CAGR of 17.5%.

Overview:

The study involved four major activities to estimate the current size of the human organoids market. Exhaustive secondary research was carried out to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171046468

Demand for liver transplants result in the segment occupying the high share of the human orgnaoids market

Liver segment owes a good market share in Human Orgnaoids market. The large share of this segment is attributed to factors such as the advancements in technology among researchers and academia (coupled with growing industry-academia collaborations for organoids research, rising numbers of liver transplants and the investments by the both private and public players in the market.

Kidney estimated to be the growing market

The kidney human orgnaoids market is expected to witness sustained demand during the forecast period, owing to the high prevalence of infectious diseases across major markets (resulting in a growing number of transplant procedures), and an increasing number of life science researches in the field of specific requirements and treatment, especially across emerging countries.

Asia Pacific likely to emerge as the fastest growing clinical microbiology market, globally

Geographically, the emerging Asian countries, such as China, India, South Korea, Taiwan, and Singapore, are offering high-growth opportunities for market players. The Asia Pacific clinical microbiology market is projected to grow at the highest CAGR of 18.8% from 2020 to 2025. Government efforts to increase awareness related to human organoids; supportive regulations for the development and commercialization of advanced human orgnaoids products; rising healthcare expenditure; the increasing number of hospitals in India and China; expanding research base across India, China, and Japan; and the increasing incidence of transpalnts are driving the growth of the APAC clinical microbiology market.

Leading Companies Operating in the Global Market:

Prominent players in this market BioIVT (US), Thermo Fisher Scientific (US), ZenBio (US), Corning (US), Organovo (US), Cyprio (France), Biopredic International (France), CELLINK (Sweden), Emulate (US), Hµrel Corporation (US), InSphero (Switzerland), Kerafast (US), Kirkstall (UK), and MIMETAS (Netherlands).

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=171046468

Key Players Operating in the Global Bowel Management System Market

 Major Growth Boosting Factors:

Growth in the bowel management system market is mainly driven by factors such as the expanding target patient population, the rapidly growing geriatric population, availability of technologically advanced bowel management products, and the favorable reimbursement scenario in developed countries.

Expected Revenue Gains:

The global bowel management systems market is projected to reach USD 2.07 billion by 2023 from USD 1.74 billion in 2018 and, at a CAGR of 3.5%.

Global Leading Companies:

Some of the major players operating in the bowel management system market are Coloplast (Denmark), Medtronic (Ireland), 3M (US), B. Braun (Germany), C.R. Bard (US), Consure Medical (India), Cogentix Medical (US), Aquaflush Medical Limited (UK), Axonics Modulation Technologies (US), ConvaTec (UK), Hollister (US), MBH-International A/S (Denmark), Mederi Therapeutics Inc. (US), Welland Medical limited (UK), and Wellspect HealthCare (Sweden).

Growth Strategies Adopted by Them:

An analysis of market developments between 2015 and 2018 revealed that growth strategies such as product launches and approvals, agreements, expansions, and acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the bowel management system market. Among these, product launches and approvals were the most widely adopted growth strategies

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=45043428

As of 2017, Coloplast (Denmark) is the key player in the global bowel management systems market. The company’s growth in the bowel management systems market is supported by its strong pipeline of products, sustained cost discipline, and adoption of new growth strategies to enhance its product portfolio based on new technologies available in the market. The company’s large share of the market was also supported by the launch of its SenSura Mio product portfolio in various important markets and the acquisitions of various regional players in the continence and ostomy market.

As of 2017, ConvaTec (UK) is among the key manufacturers of bowel management systems. The company markets a comprehensive product portfolio of ostomy systems, accessories, and fecal incontinence products to address customer needs and preferences.

As of 2017, Hollister (US) holds a significant share in the global bowel management system market owing to its targeted product portfolio of bowel care products, which serves as an important factor for its future growth. The company is focusing on expanding its presence across the globe through various inorganic strategies. In May 2018, the company established a new distribution center in Oud Gastel, in the Netherlands. This new center is aimed at catering to the growing customer needs and it will help the company strengthen its presence in the European region. Thus, with the growing efforts of the company to expand its critical care segment, the company is expected to witness growth in the bowel management systems market in the coming years.

In 2018, Europe accounted for the largest share of the bowel management systems market

Geographically, the bowel management system market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Europe accounted for the largest share of the market in 2018. The large share can be attributed to the significant disease (colorectal/bladder cancer & IBD) burden, favorable reimbursement scenario, and the increase in its geriatric population.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=45043428

Healthcare Contract Management Software Market worth $1,763 Million by 2024

 Major Growth Driving Factors:

The growing need to increase the operational efficiency of healthcare organizations while decreasing operational costs, increasing need to maintain compliance with regulatory mandates, high returns on investment are the major factors driving the growth of healthcare contract management software market.

Expected Revenue Surge:

The healthcare contract management software market is projected to reach USD 1,763 million by 2024 from USD 755 million in 2019, at a CAGR of 18.5% during the forecast period.

Global Industry Dynamics:

“The software segment is expected to dominate the market in 2019.”

On the basis of products and services, the healthcare contract management software market is segmented into software and services. The software segment is expected to grow at the highest CAGR during the forecast period. The high growth in this segment can be attributed to the benefits offered by healthcare contract management software, such as increased visibility, improved efficiency, minimized contract risks, and improved payment accuracy & agility, among others.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=114258694

“By end user, the healthcare payers segment is expected to grow at the highest CAGR during the forecast period.”

Based on end user, the healthcare contract management software market has been segmented into healthcare providers, healthcare payers, medical device manufacturers and pharma & biotech companies, and research organizations. The healthcare payers segment is expected to grow at the highest CAGR during the forecast period. The need to accelerate medical claims processing tasks, increase drafting efficiency, align contracts with physician groups and facilities, and integrate contract data with downstream claims or reimbursement systems is expected to drive the growth of the healthcare payers segment.

“North America to hold the largest regional market share in 2019.”

North America is expected to account for the largest share of the healthcare contract management software market in 2019, followed by Europe. The large share of North America can be attributed to the favorable regulations (such as the Meaningful Use and Health Insurance Portability & Accountability Act) combined with the large number of hospitals and the presence of a number of private insurance players. In addition, well-established government payers are further supporting the growth of this market.

Global Key Players:

The prominent players in this market are Determine Inc. (US), CobbleStone Software (US), Concord (US), Contract Logix LLC (US), Icertis (US), Apttus Corporation (US), Coupa Software Inc. (US), Optum Inc. (US), nThrive Inc. (US), Experian Plc. (Ireland), and ScienceSoft (US).

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=114258694

Ablation Technology Market to Generate Revenue Worth $8.1 Billion by 2026

 Global Growth Influencing Factors:

The growing elderly population has also driven the incidence of target conditions and contributed to the demand for effective treatment. However, the reuse and reprocessing of devices in developed countries and unfavorable regulatory scenario are key factors limiting the growth of this market. Product recalls and therapeutic challenges related to the efficacy of ablation products are key challenges faced by industry players in the global ablation technology market.

Projected Rise in Revenue Growth:

The ablation technology market is projected to reach USD 8.1 Billion by 2026 from USD 5.2 Billion in 2021, at a CAGR of 9.3% during the forecast period.

Data Triangulation:

After arriving at the overall size of the global ablation technology market through the above-mentioned methodology, this market was split into several segments and sub-segments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and sub-segments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both the demand- and supply-side participants.

Opportunity: Growth potential in emerging economies

Emerging markets, including India, China, Mexico, and Brazil, offer significant growth opportunities in the ablation technology market, owing to factors such as initiatives undertaken by stakeholders across these countries, low regulatory barriers for trade, continuous improvements in the healthcare infrastructure, growing patient population, the relatively low procedural cost for disease treatment (compared to developed countries), less stringent regulatory policies, low competition, and rising healthcare expenditure. Moreover, these regions have reported growth in the incidence and prevalence of lifestyle diseases such as cardiac diseases and cancer

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=791

Challenge: Reuse and reprocessing of devices

As per the FDA and EU guidelines, ablation catheters are labeled as single-use devices (SUDs). However, the high per-unit cost and limited reimbursement have led to reprocessing and reuse in hospitals with budget constraints. The cost incurred by a hospital/surgical center for reprocessing and reuse is less than 10% compared to the cost of a new ablation device, reducing the overall procedural cost by around 50%. Germany is among the key European countries that allow the reuse of SUDs (including ablation catheters), provided the devices are reprocessed as per regulatory guidelines. Furthermore, the US has also looked favorably on reprocessing SUDs—according to current FDA clearances, fully leveraging single-use device reprocessing can save US healthcare more than USD 700 million (Source: MPO Summit, 2021)

In terms Application, the cardiovascular treatment segment is expected to account for the largest share of the ablation technology market in 2020.

Based on application, the ablation technology market is classified into major segments—cardiovascular disease treatment, cancer treatment, ophthalmological treatment, pain management, gynecological treatment, urological treatment, orthopedic treatment, cosmetic/aesthetic surgery, and other applications. Rising disease prevalence and technological advancement in this field will boost market growth.

The hospitals, surgical centers, and ablation centers segment is expected to register the highest CAGR during the forecast period

The ablation technology market, by end user, is segmented into hospitals, surgical centers, and ablation centers, ambulatory surgical centers (ASCs), medical spas & aesthetic centers, and other end users. The increasing incidence of cancer, sports injuries, and cardiac conditions is driving the growth of the ablation technology market for hospitals, surgical centers, and ablation centers segment.

Asia Pacific market is expected to grow at the highest CAGR during the forecast period.

The ablation technology market covers five key geographies—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2020, Asia Pacific region offered significant opportunities for the growth of the ablation technology market. The market growth in Asia Pacific can be attributed rising incidence and prevalence of cancer and cardiac conditions, technological advancement in ablation product and technology, increasing awareness of minimally invasive techniques and growth opportunities in the emerging markets.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=791

Global Apheresis Market to Grow Worth $2.7 billion by 2025

 Global Growth Driving Factors:

The rising prevalence of chronic diseases and the growing number of trauma & injury cases, the rising demand for blood components and growing concerns regarding blood safety, and the favorable reimbursement for apheresis procedures are the major factors driving the growth of apheresis market.

Projected Revenue Surge:

The global apheresis market is projected to reach USD 2.7 billion by 2025 from USD 1.7 billion in 2019, at a CAGR of 8.1% during the forecast period.

The centrifugation technology segment is expected to grow at the highest CAGR during the forecast period

Based on technology, the apheresis market is segmented into centrifugation technology and membrane separation technology. The centrifugation segment is expected to grow at the highest CAGR during the forecast period. This high growth can be attributed to the advantages offered by centrifugation over membrane separation, such as its high efficiency and its ability to separate all types of blood components

The photopheresis segment is expected to grow at the highest CAGR during the forecast period

Based on application, the apheresis market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, photopheresis, and other applications. The photopheresis is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing prevalence of blood disorders and the rising demand for photopheresis in organ transplant rejection treatment.

The disposables segment is expected to grow at the highest CAGR during the forecast period

Based on products, the apheresis market is segmented into devices and disposables. The disposable segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to its recurrent use, increasing blood donations using apheresis devices, an increasing number of therapeutic apheresis procedures, and favorable reimbursement policies for apheresis procedures.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=950

The therapeutic apheresis segment is expected to grow at the highest CAGR during the forecast period

Based on procedure, the apheresis market is segmented into automated blood collection (donor apheresis) and therapeutic apheresis. The therapeutic apheresis segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be attributed to the increasing adoption of apheresis procedures for the treatment of various neurological, blood, and renal diseases; the increasing prevalence of blood disorders; and favorable reimbursement policies for apheresis procedures.

The hospitals and transfusion centers segment is expected to grow at the highest CAGR during the forecast period

On the basis of end user, the apheresis market has been segmented into blood collection centers and blood component providers, hospitals and transfusion centers, and other end users. The hospitals and transfusion centers segment is estimated to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing adoption of therapeutic apheresis in the treatment of various diseases, growing indications of therapeutic apheresis, and rising awareness of apheresis as a therapy.

North America accounted for the largest market share in 2018

North America accounted for the largest share of the apheresis market in 2018, followed by Europe. The large share of this region can be attributed to easier accessibility to advanced blood collection technologies, the presence of established healthcare infrastructure, and the increasing presence of leading apheresis companies in the country.

Key Players:

The prominent players in this market are Terumo BCT, Inc. (US), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), Nikkiso Co., Ltd. (Japan), Macopharma SA (France), Miltenyi Biotec (Germany), Otsuka Holdings Co. Ltd. (Japan), Medica S.p.A. (Italy), Mallinckrodt plc (Ireland), Medicap Clinic GmbH (Germany), Lmb Technologies GmbH (Germany), Bioelettronica (Italy), Infomed (Switzerland), Cytosorbents Corporation (US), and Toray Medical Co. Ltd. (Japan), among other key players.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=950

Medical Equipment Maintenance Market - Global Segmentation & Future Forecasts

 Major Growth Driving Factors:

The growth for medical equipment maintenance market can be attributed to the increasing demand for Maintenance programs include processes for the preventive, corrective, and operational maintenance of medical devices, ensuring that the equipment is safe for both patients and operators. Service provider also provide training programs along with maintenance services attributed to growing preference for long term service contracts. Factors such as the COVID-19 pandemic, rapidly growing global geriatric population, changing epidemiology, and the cost-effectiveness of maintenance services have driven the medical equipment maintenance market for healthcare sector.

Revenue Growth Expectations:

The medical equipment maintenance market is expected to witness sustained and positive demand growth during the forecast period. The medical equipment maintenance market is projected to reach USD 74.2 billion by 2026 from USD 45.2 billion in 2021 at a CAGR of 10.4% during the forecast period.

Global Industry Segmentation:

Based on device type, the medical equipment maintenance market is segmented into diagnostic imaging equipment, patient monitoring & life support devices, endoscopic devices, surgical equipment, ophthalmology equipment, medical lasers, electrosurgical equipment, radiotherapy devices, dental equipment, laboratory equipment, and durable medical equipment. In 2020, the diagnostic imaging equipment segment accounted for the largest share of the medical equipment maintenance market. This segment is also expected to record the highest CAGR during the forecast period. The increasing demand for maintenance services for diagnostic imaging equipment is attributed to their substantial replacement cost and the need to ensure maximum equipment uptime.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=69695102

Based on service type, the medical equipment maintenance market is segmented into corrective, preventive, and operational maintenance. The preventive maintenance segment is estimated to dominate the medical equipment maintenance market in 2020. The growing focus on implementing preventive maintenance strategies among healthcare organizations is expected to offer growth opportunities for service providers in the coming years.

Based on a service provider, the medical equipment maintenance market has been segmented into multi-vendor OEMs, single-vendor OEMs, ISOs, and in-house maintenance. Among these, the multi-vendor OEMs segment accounted for the largest share of the market in 2020. Many healthcare providers opt for maintenance services offered by OEMs owing to their service quality, wide geographic presence, strong technical expertise, and easy access to spare parts (resulting in reduced downtime). Also, multi-vendor service contracts eliminate the complexity of dealing with multiple OEMs and external suppliers.

End Users:

Based on end user, the medical equipment maintenance market is segmented into hospitals, diagnostic imaging centers, dialysis centers, ambulatory surgical centers, dental clinics & specialty clinics, and other end users. In 2020, hospitals accounted for the largest share of this market. The rising patient influx is encouraging hospitals to form alliances and partnerships with medical device maintenance service vendors for the establishment of state-of-the-art in-house maintenance facilities or outsourcing maintenance services.

Geographical Growth Dynamics:

The medical equipment maintenance market covers five key geographies—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2020, Asia Pacific region is expected to offer significant opportunities for the growth of the medical equipment maintenance market. This is because of the region’s large population and its mix of growing and developed economies, such as Japan, China, and India.

In addition, markets in developed countries are becoming increasingly saturated, thereby having manufacturers and suppliers shift their focus to Asian markets. In 2020, Asia Pacific region is expected to offer significant opportunities for the growth of the medical equipment maintenance market. Presence of a large number of OEMs, and strategic agreements and collaborations between service providers and end users are the major factors driving the growth of the medical equipment maintenance market.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=69695102

Respiratory Care Devices Market - Revenue Growth Expectations by 2026

 Overview of This Study:

This study involved four major activities for estimating the current size of the global respiratory care devices market. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets.

The next step focused on validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the sizes of segments and sub-segments.

Projected Revenue Surge:

The respiratory care devices market is expected to reach USD 27.6 billion by 2026 from USD 18.4 billion in 2021, at a CAGR of 8.5% during the forecast period of 2021 to 2026.

Major Growth Driving Factors:

Due to the outbreak of corona virus globally, there is a sudden rise in the demand for respiratory care devices. The growth of this market is mainly attributed to the high prevalence of respiratory diseases, rising aging population across the globe, high prevalence of smoking, rising urbanization and pollution levels, increasing incidence of preterm births, and lifestyle changes. However, a lack of awareness—leading to a large underdiagnosed and undertreated population—and the harmful effects of certain respiratory care devices on neonates have hampered market growth to an extent.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=368

COVID-19 Impact on the Global Respiratory Care Devices Market

The COVID-19 outbreak in Wuhan, China, led to the rapid establishment of several hospitals for treating the increasing number of patients. This has been mirrored in other countries as well—Italy and the US also built large hospitals within days to accommodate a growing patient population. In New York, US, the army converted the Javits convention center into a 2,900-bed hospital within four days. Critical care devices are being manufactured in increased quantities to meet growing demand. The state of affairs resulting from the pandemic has resulted in alliances between healthcare and non-healthcare industries to manufacture respiratory care devices.

Opportunities: Growing demand for home care therapeutic devices

The rapid growth in the global geriatric population, rising incidence of chronic diseases (including COPD and asthma), and the cost advantages of home care devices and services (compared to hospital visits) are the key factors driving the growth of the home healthcare market. The high growth potential in emerging markets, healthcare decentralization, and the evolution of miniaturized devices are some of the major factors that are expected to provide significant growth opportunities to players operating in the respiratory home healthcare market.

Owing to the rising healthcare costs, a large number of patients suffering from chronic respiratory diseases prefer to undergo treatments in home care settings. This trend is expected to increase the demand for products such as nebulizers, ventilators, and CPAP devices, as they are used by patients to treat, diagnose, and monitor a variety of respiratory diseases in home care settings.

Geographical Growth Scenario:

The global respiratory care devices market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of this market. The large share of the North American region is mainly attributed to the strong presence of a large number of major manufacturers, its rising geriatric population, high prevalence of smoking and respiratory diseases, and the presence of a highly developed healthcare system.

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, due to its large patient pool for respiratory diseases, growing healthcare expenditure, and developments in healthcare infrastructure.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=368

Clinical Trial Supplies Market - Global Industry Segmentation & Future Growth Trends

 Overview:

This market research study involves the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global clinical trial supplies market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess market prospects. The clinical trial supplies market size was estimated through various secondary research approaches and triangulated with inputs from primary research.

Expected Revenue Growth:

The global clinical trial supplies market is projected to reach USD 2.9 billion by 2026 from USD 1.9 billion in 2021, at a CAGR of 8.5% during the forecast period of 2021 to 2026.

Major Industry Growth Drivers:

Market growth is largely driven by the increasing R&D expenditure in pharmaceutical and biopharmaceutical companies and the growing number of clinical trials conducted globally. However, the increasing cost of drug development and clinical trials is expected to restrain the growth of this market during the forecast period.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=172240059

Global Industry Segmentation:

Based on the therapeutic area, the clinical trial supplies market is segmented into oncology, CNS & mental disorders, cardiovascular diseases, digestive disorders, infectious diseases, metabolic disorders, immunology, blood disorders, and other therapeutic areas (respiratory disorders, dermatological disorders, rare diseases, ENT diseases, Nephrology) Oncology is the largest segment in this market owing to the high and growing number of research studies on cancer therapeutics and the increasing number of companies focusing on bringing innovative cancer drugs into the market. The oncology segment is projected to register the highest CAGR during the forecast period.

Based on end users, the clinical trial supplies market is categorized into three segments—pharmaceutical & biotechnology companies, contract research organizations (CROs), and medical device companies. These end users use clinical trial services for various activities in the supply chain like comparator sourcing, manufacturing, packaging, labeling, storage, and retention. The pharmaceutical and biotechnology companies accounted for the largest share of 70% of this market in 2020. This share is attributed to the rising R&D efforts by these companies. The fastest-growing segment is the CROs owing to the increasing outsourcing of clinical research by companies.

Geographical Growth Scenario:

Based on the region, the clinical trial supplies market is broadly segmented into North America, Europe, the Asia Pacific, and the Rest of the World. North America is the largest regional market for clinical trial supplies, with an estimated share of around 42% in 2020; Europe is the second-largest regional market with a share of around 28%.

Growth in these markets is primarily driven by the presence of well-established CROs and the rising R&D expenditure by pharmaceutical & biopharmaceutical companies. However, the Asia Pacific market is projected to register the highest growth during the forecast period due to the presence of many emerging players, less-stringent regulations, and the ease and cost-effectiveness of patient recruitment in APAC countries.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=172240059